Article info

Download PDFPDF

Altria-Juul Labs deal: why did it occur and what does it mean for the US nicotine delivery product market

Authors

  1. Correspondence to Dr David T Levy, Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washinton, DC 20007, USA; dl777{at}georgetown.edu
View Full Text

Citation

Levy DT, Sweanor D, Sanchez-Romero LM, et al
Altria-Juul Labs deal: why did it occur and what does it mean for the US nicotine delivery product market

Publication history

  • Received March 29, 2019
  • Revised July 12, 2019
  • Accepted July 17, 2019
  • First published September 4, 2019.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.